Lee Pharma v. AstraZeneca- An unfinished Patent Story
This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need,…
Patents Act 1970
26 articles
PIL, IPO and Statement of Working of Patents
This post explores the statutory requirements for the statement of working of patents in India, assessing the legal provisions and practical challenges faced by the patent office. It…
New Computer Related Inventions Guidelines
The Indian Patent Office has replaced earlier provisions with new Guidelines for Computer Related Inventions, clarifying patentability criteria under section 3k of the Patents Act. The Guidelines provide…
Introduction to Pre-grant & Post-grant Oppositions to Patent Applications
This post provides an analytical overview of pre-grant and post-grant opposition provisions in Indian patent law. It explains the procedural and substantive changes introduced by the Patents (Amendment)…
Drug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…
Request for Examination of a Patent Application – Mandatory Requirement in India
Filing a request for examination is a mandatory requirement for patent applications in India. The request must be made within 48 months, using Form-18 and the prescribed fee,…